Retour
Fourchette du Jour
61,41 €
64,25 €
Fourchette 52 Semaines
45,00 €
85,84 €
Volume
660 334
Moyenne 50J / 200J
69,11 €
/
69,40 €
Clôture Précédente
61,49 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | -256,9 | 0,4 |
| P/B | 4,4 | 2,9 |
| ROE % | -1,9 | 3,8 |
| Net Margin % | -0,9 | 3,9 |
| Rev Growth 5Y % | 11,6 | 10,0 |
| D/E | 1,7 | 0,2 |
Points Clés
Revenue grew 11,60% annually over 5 years — strong growth
Earnings declined -767,81% over the past year
Generating 85,57M in free cash flow
PEG of 0,38 suggests growth is underpriced
ROIC of 2,31% — low return on invested capital
Interest coverage of 1,30× — tight debt servicing
Croissance
Revenue Growth (5Y)
11,60%
Revenue (1Y)11,51%
Earnings (1Y)-767,81%
FCF Growth (3Y)39,04%
Qualité
Return on Equity
-1,87%
ROIC2,31%
Net Margin-0,91%
Op. Margin4,45%
Sécurité
Debt / Equity
1,71
Current Ratio1,76
Interest Coverage1,30
Valorisation
P/E Ratio
-256,90
P/B Ratio4,40
EV/EBITDA64,79
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 11,51% | Revenue Growth (3Y) | 12,34% |
| Earnings Growth (1Y) | -767,81% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 11,60% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 2,04B | Net Income (TTM) | -18,65M |
| ROE | -1,87% | ROA | -0,50% |
| Gross Margin | 4,45% | Operating Margin | 4,45% |
| Net Margin | -0,91% | Free Cash Flow (TTM) | 85,57M |
| ROIC | 2,31% | FCF Growth (3Y) | 39,04% |
| Safety | |||
| Debt / Equity | 1,71 | Current Ratio | 1,76 |
| Interest Coverage | 1,30 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | -256,90 | P/B Ratio | 4,40 |
| P/S Ratio | 2,35 | PEG Ratio | 0,38 |
| EV/EBITDA | 64,79 | Dividend Yield | 0,00% |
| Market Cap | 4,79B | Enterprise Value | 5,88B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 2,04B | 1,83B | 1,62B | 1,43B | 1,32B |
| Net Income | -18,65M | 2,79M | 3,04M | 10,65M | 24,73M |
| EPS (Diluted) | -0,25 | 0,04 | 0,05 | 0,17 | 0,46 |
| Gross Profit | 90,80M | 249,12M | 221,39M | 165,72M | 191,80M |
| Operating Income | 90,80M | 104,62M | 98,70M | 46,36M | 82,55M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 3,76B | 3,29B | 2,69B | 2,43B | 2,06B |
| Total Liabilities | 2,40B | 2,15B | 1,88B | 1,94B | 1,71B |
| Shareholders' Equity | 1,09B | 902,31M | 630,70M | 333,00M | 228,90M |
| Total Debt | 1,86B | 1,73B | 1,49B | 1,51B | 1,40B |
| Cash & Equivalents | 767,22M | 740,02M | 342,57M | 127,83M | 134,61M |
| Current Assets | 1,03B | 1,02B | 579,28M | 367,18M | 324,26M |
| Current Liabilities | 586,76M | 479,71M | 437,45M | 466,72M | 374,78M |